BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 32556969)

  • 1. Use of Butorphanol as Treatment for Cholestatic Itch.
    Golpanian RS; Yosipovitch G; Levy C
    Dig Dis Sci; 2021 May; 66(5):1693-1699. PubMed ID: 32556969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial.
    Bolier R; de Vries ES; Parés A; Helder J; Kemper EM; Zwinderman K; Elferink RPO; Beuers U;
    Trials; 2017 May; 18(1):230. PubMed ID: 28535810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis and Management of Pruritus in PBC and PSC.
    Kremer AE; Namer B; Bolier R; Fischer MJ; Oude Elferink RP; Beuers U
    Dig Dis; 2015; 33 Suppl 2():164-75. PubMed ID: 26641452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Butorphanol for treatment of intractable pruritus.
    Dawn AG; Yosipovitch G
    J Am Acad Dermatol; 2006 Mar; 54(3):527-31. PubMed ID: 16488311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The challenge of cholestatic pruritus.
    Bolier AR; Peri S; Oude Elferink RP; Beuers U
    Acta Gastroenterol Belg; 2012 Dec; 75(4):399-404. PubMed ID: 23402082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis and treatment of pruritus in cholestasis.
    Kremer AE; Beuers U; Oude-Elferink RP; Pusl T
    Drugs; 2008; 68(15):2163-82. PubMed ID: 18840005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in pathogenesis and management of pruritus in cholestasis.
    Kremer AE; Bolier R; van Dijk R; Oude Elferink RP; Beuers U
    Dig Dis; 2014; 32(5):637-45. PubMed ID: 25034299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review.
    Phan NQ; Lotts T; Antal A; Bernhard JD; Ständer S
    Acta Derm Venereol; 2012 Sep; 92(5):555-60. PubMed ID: 22504709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholestatic pruritus: Emerging mechanisms and therapeutics.
    Patel SP; Vasavda C; Ho B; Meixiong J; Dong X; Kwatra SG
    J Am Acad Dermatol; 2019 Dec; 81(6):1371-1378. PubMed ID: 31009666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifampicin as treatment for pruritus in malignant cholestasis.
    Price TJ; Patterson WK; Olver IN
    Support Care Cancer; 1998 Nov; 6(6):533-5. PubMed ID: 9833303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron.
    Schwörer H; Hartmann H; Ramadori G
    Pain; 1995 Apr; 61(1):33-37. PubMed ID: 7644246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial.
    de Vries E; Bolier R; Goet J; Parés A; Verbeek J; de Vree M; Drenth J; van Erpecum K; van Nieuwkerk K; van der Heide F; Mostafavi N; Helder J; Ponsioen C; Oude Elferink R; van Buuren H; Beuers U;
    Gastroenterology; 2021 Feb; 160(3):734-743.e6. PubMed ID: 33031833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Characterization of a Novel Mouse Model of Cholestatic Pruritus.
    Andoh T; Suzuki K; Konno M; Tsuneyama K; Kuraishi Y
    Biol Pharm Bull; 2020; 43(7):1111-1117. PubMed ID: 32612073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of cholestatic pruritus in children.
    Cies JJ; Giamalis JN
    Am J Health Syst Pharm; 2007 Jun; 64(11):1157-62. PubMed ID: 17519457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety considerations for the management of cholestatic itch.
    Trivella J; Levy C
    Expert Opin Drug Saf; 2021 Aug; 20(8):915-924. PubMed ID: 33836644
    [No Abstract]   [Full Text] [Related]  

  • 16. Cholestatic Itch Management.
    Mittal A
    Curr Probl Dermatol; 2016; 50():142-8. PubMed ID: 27578083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of pruritus in cholestasis: understanding and treating the itch.
    Beuers U; Wolters F; Oude Elferink RPJ
    Nat Rev Gastroenterol Hepatol; 2023 Jan; 20(1):26-36. PubMed ID: 36307649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis and management of pruritus in cholestatic liver disease.
    Imam MH; Gossard AA; Sinakos E; Lindor KD
    J Gastroenterol Hepatol; 2012 Jul; 27(7):1150-8. PubMed ID: 22413872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholestatic pruritus : an update.
    De Vloo C; Nevens F
    Acta Gastroenterol Belg; 2019; 82(1):75-82. PubMed ID: 30888758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transnasal butorphanol for the treatment of opioid-induced pruritus unresponsive to antihistamines.
    Dunteman E; Karanikolas M; Filos KS
    J Pain Symptom Manage; 1996 Oct; 12(4):255-60. PubMed ID: 8898510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.